跳至主要内容
临床试验/IRCT2014121920366N1
IRCT2014121920366N1已完成1 期

The Effects of Portulaca oleracea Extract capsule on inflammatory biomarkers, lipid profile and serum glucose, anthropometric indices and blood pressure in adult with Metabolic syndrome for prevention of heart disease.

Vice chancellor for research,Isfahan University of Medical Science0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
27 years 至 59 years(—)
性别
Male

入选标准

  • persons suffering from obesity as defined by the IDF (WC= 102 in men) and have 2 signs of the 4 following symptoms, the metabolic syndrome was diagnosed. In this study, the characteristics of metabolic syndrome will be considered, if the criteria were the terms of this syndrome (having 2 of the first 4), other criteria will be checked:
  • 1-high blood pressure (systolic>130mhg and diastolic>85mmhg); 2-fasting blood glucose>100mg/dl; 3-TG>150mg/dl; 4-HDL<40mg/dl; -gender: male; no history of cancer, kidney, thyroid, diabetes, and anemia; lack of use of alcohol and drugs; no smoking history or drug allergy; no special diet; no change in medication in the last three months; lack of drugs that control blood sugar, lipid and blood pressure; no taking medications affecting inflammation, such as corticosteroids.
  • Exclusion criteria: during the study , patients who lose their inclusion criteria, including smoking; suffering from diseases such as heart problems , kidney , thyroid and digestive disorders and lack of cooperation.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Isfahan University of Medical Science

相似试验